Amgen deal triggers watchful waiting in targeted nanomedicine.Published in:Nature Medicine, 2013, v. 19, n. 2, p. 120, doi. 10.1038/nm0213-120bBy:Heger, MonicaPublication type:Article
Russian fund steps up investments in innovative biotechs.Published in:Nature Biotechnology, 2012, v. 30, n. 1, p. 9, doi. 10.1038/nbt0112-9aBy:Katsnelson, AllaPublication type:Article